Cargando…
Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732266/ https://www.ncbi.nlm.nih.gov/pubmed/33324950 http://dx.doi.org/10.1097/HS9.0000000000000504 |
| _version_ | 1783622054787940352 |
|---|---|
| author | van der Horst, Hilma J. Oostindie, Simone C. Cillessen, Saskia. A. G. M. Gelderloos, Anne T. Overdijk, Marije B. Nijhof, Inger. S. Zweegman, Sonja Chamuleau, Martine E. D. Breij, Esther C. W. Mutis, Tuna |
| author_facet | van der Horst, Hilma J. Oostindie, Simone C. Cillessen, Saskia. A. G. M. Gelderloos, Anne T. Overdijk, Marije B. Nijhof, Inger. S. Zweegman, Sonja Chamuleau, Martine E. D. Breij, Esther C. W. Mutis, Tuna |
| author_sort | van der Horst, Hilma J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7732266 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77322662020-12-14 Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies van der Horst, Hilma J. Oostindie, Simone C. Cillessen, Saskia. A. G. M. Gelderloos, Anne T. Overdijk, Marije B. Nijhof, Inger. S. Zweegman, Sonja Chamuleau, Martine E. D. Breij, Esther C. W. Mutis, Tuna Hemasphere Letter Lippincott Williams & Wilkins 2020-12-09 /pmc/articles/PMC7732266/ /pubmed/33324950 http://dx.doi.org/10.1097/HS9.0000000000000504 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Letter van der Horst, Hilma J. Oostindie, Simone C. Cillessen, Saskia. A. G. M. Gelderloos, Anne T. Overdijk, Marije B. Nijhof, Inger. S. Zweegman, Sonja Chamuleau, Martine E. D. Breij, Esther C. W. Mutis, Tuna Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies |
| title | Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies |
| title_full | Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies |
| title_fullStr | Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies |
| title_full_unstemmed | Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies |
| title_short | Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies |
| title_sort | potent preclinical efficacy of duohexabody-cd37 in b-cell malignancies |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732266/ https://www.ncbi.nlm.nih.gov/pubmed/33324950 http://dx.doi.org/10.1097/HS9.0000000000000504 |
| work_keys_str_mv | AT vanderhorsthilmaj potentpreclinicalefficacyofduohexabodycd37inbcellmalignancies AT oostindiesimonec potentpreclinicalefficacyofduohexabodycd37inbcellmalignancies AT cillessensaskiaagm potentpreclinicalefficacyofduohexabodycd37inbcellmalignancies AT gelderloosannet potentpreclinicalefficacyofduohexabodycd37inbcellmalignancies AT overdijkmarijeb potentpreclinicalefficacyofduohexabodycd37inbcellmalignancies AT nijhofingers potentpreclinicalefficacyofduohexabodycd37inbcellmalignancies AT zweegmansonja potentpreclinicalefficacyofduohexabodycd37inbcellmalignancies AT chamuleaumartineed potentpreclinicalefficacyofduohexabodycd37inbcellmalignancies AT breijesthercw potentpreclinicalefficacyofduohexabodycd37inbcellmalignancies AT mutistuna potentpreclinicalefficacyofduohexabodycd37inbcellmalignancies |